Onemednet Corp

Onemednet Corp(ONMD)股票分析

$5.139

+1.194 (+23.24%)收盘时

Loading chart…
最高
5.250
开盘
4.470
成交量加权均价
4.94
成交量
70.88K
市值
—
最低
4.430
成交额
350.13K
企业价值/息税折旧摊销前利润(TTM)
0.00

OneMedNet Corporation is a global provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data (RWD), through its OneMedNet iRWD solution. The Company provides solutions within the clinical image archives of healthcare providers. It de-identifies, searches, and curates a data archive locally, bringing a wealth of internal and third-party research opportunities to providers. By leveraging this extensive federated provider network, together with technology and in-house clinical expertise, the Company meets the rigorous RWD life science requirements. OneMedNet iRWD offers advanced technology, clinical expert curation, and service. Medical imaging and associated clinical data are indexed at each network site using artificial intelligence (AI)/ machine learning (ML) technology. This includes EHR, radiology, cardiology, lab, path, and others. In addition to its customized data packages, it also offers regulatory-grade, pre-packaged imaging RWD sets.

AI 分析 of Onemednet Corp (ONMD)

买入

Onemednet Corp appears to be a good buy right now due to its recent significant revenue growth of 242% from Q2 2026 and a strong 21.78% increase in stock price over the last five days. However, the company still faces risks with a current ratio of only 0.28, indicating potential liquidity issues.

估值指标

Onemednet Corp(ONMD)当前预期市盈率为 0.00,5 年平均预期市盈率为 0.00。

预期市盈率

严重低估
5 年均值 P/E
0.00
当前P/E
0.00
高估
0.00
低估
0.00

预期 EV/EBITDA

严重低估
5 年均值 EV/EBITDA
0.00
当前EV/EBITDA
0.00
高估
0.00
低估
0.00

预期市销率

严重低估
5 年均值 P/S
0.00
当前P/S
0.00
高估
0.00
低估
0.00

Alphio AI 对 ONMD 的价格情景

情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

乐

乐观

乐观 · 25%ONMD

$0.77

情景价格

基

基准

基准 · 50%ONMD

$0.68

情景价格

悲

悲观

悲观 · 25%ONMD

$0.57

情景价格

持有 ONMD 的大户

E

Exencial Wealth Advisors, LLC

+ 持有ONMD

-2.95%

3个月收益率

事件时间线

2026-11-04 (ET)

09:30:00

OneMedNet Receives Mid Six-Figure Reorder to Support AI Radiology Model Development

2026-11-03 (ET)

09:00:00

OneMedNet Secures High Six-Figure Add-On Order, Data Volume Up 150%

2026-10-19 (ET)

09:30:00

OneMedNet Partners with Pharma Intelligence Provider

2026-10-07 (ET)

09:00:00

OneMedNet Partners with Mediplexus for Data Supply

2026-09-30 (ET)

09:00:00

OneMedNet Signs Seven-Figure Multi-Year Agreement

资讯

ONMD 常见问题 —— 由 Alphio AI 解答

OneMedNet Corporation is a global provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data (RWD), through its OneMedNet iRWD solution. The Company provides solutions within the clinical image archives of healthcare providers. It de-identifies, searches, and curates a data archive locally, bringing a wealth of internal and third-party research opportunities to providers. By leveraging this extensive federated provider network, together with technology and in-house clinical expertise, the Company meets the rigorous RWD life science requirements. OneMedNet iRWD offers advanced technology, clinical expert curation, and service. Medical imaging and associated clinical data are indexed at each network site using artificial intelligence (AI)/ machine learning (ML) technology. This includes EHR, radiology, cardiology, lab, path, and others. In addition to its customized data packages, it also offers regulatory-grade, pre-packaged imaging RWD sets. It operates in the Industrials sector (COMMERCIAL PHYSICAL AND BIOLOGICAL RESEARCH industry).

Onemednet Corp appears to be a good buy right now due to its recent significant revenue growth of 242% from Q2 2026 and a strong 21.78% increase in stock price over the last five days. However, the company still faces risks with a current ratio of only 0.28, indicating potential liquidity issues.

暂无帖子

注册或登录后参与讨论

相关文章

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易